Dr. Bashar G. Saad, MD

Dr. Saad practices at Bashar G Saad MD Inc in Glendora, California.

Dr. Saad's NPI, 1275611360, was assigned on November 2, 2006. Dr. Saad graduated from Damascus University Faculty of Medicine in 1987. Dr. Saad holds California license A52007.

Dr. Saad's primary practice is Bashar G Saad MD Inc, at 210 S Grand Ave, Glendora, CA 91741 in Los Angeles County. The practice phone is (626) 335-8094.

Dr. Saad's primary practice is Bashar G Saad MD Inc in Glendora, California. Dr. Saad is also affiliated with Emanate Health Foothill Presbyterian Hospital. The medical group on file is Bashar G. Saad, MD. Dmand AI also links Dr. Saad to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saad practices, 7 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Saad's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dmand AI has Dr. Saad's licenses on file in 2 states: California and Louisiana.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, high cholesterol, hypercalcemia, obesity and osteoporosis among the conditions Dr. Saad treats.

CMS data shows 2,728 Medicare services from Dr. Saad across 11 procedure codes in 2024, for 1,167 Medicare patients. Medicare paid $254,269 for them.

CMS counts 1,167 Medicare patients who saw Dr. Saad in 2024. The largest group is 65 to 74, with 563 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saad's median patient age at 63, with 66% women.

In 2024, Dr. Saad wrote 23,942 Medicare Part D claims for 2,808 patients. 46% of them were for generic drugs. CMS names the drug for 23,300 of them, across 152 drugs with 11 or more claims each, at $8,811,893 in total drug cost. In 2023, CMS named 20,291 claims across 158 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Saad for performance year 2024, reported as part of a group. Dr. Saad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Saad, published from 2011 to 2024. 2015 was the busiest year, with 4. The most frequent topics are Antineoplastic Agents, Arabs and Complementary Therapies. Dr. Saad has published most often in Evid Based Complement Alternat Med. Dr. Saad's most frequent co-authors are Amitava Michael Dasgupta, MD and Mutahir Farhan, MD.

CMS Open Payments shows 3,153 general payments to Dr. Saad from 78 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $74,301.

Dmand AI lists 4 awards for Dr. Saad, most recently Top Doctors:LA Area in 2013.

Dr. Saad graduated from Damascus University Faculty of Medicine in 1987.

Dr. Saad is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.